Renal Cancer
Histone-dependent PARP-1 inhibitors: A novel therapeutic modality for the treatment of prostate and renal cancers.
May 18, 2020
Clinicopathological Significance of MTUS1 Expression in Patients With Renal Cell Carcinoma.
May 15, 2020
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
May 14, 2020